The invention belongs to the technical field of medicine, and relates to a traditional Chinese medicine for treating vaginal bleeding after medical abortion. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 9-15 parts of Panax ginseng, 20-28 parts of Angelica sinensis, 6-12 parts of Ligusticum chuanxiong, 3-9 parts of Semen Persicae, 2-4 parts of dried ginger, 2-4 parts of processed radix glycyrrhizae, 20-28 parts of Agrimonia pilosa, 20-28 parts of lotus rhizome node, 9-15 parts of Hibiscus rosa-sinensis flower, 7-13 parts of Radix Rubiac Cordifoliae, 6-12 parts of Fineleaf Schizonepeta Herb, 7-13 parts of Paeonia suffruticosa bark, 7-13 parts of ass-hide glue, 2-4 parts of Squama manitis, 3-9 parts of parched Vaccaria segetalis, 3-9 parts of Radix Arnebiae, 3-9 parts of Scrophularia ningpoensis, and 2-4 parts of Panax notoginseng powder. According to clinical trial results, the cure rate is 82.0% and the total effective rate is 98.0% in the observation group of the traditional Chinese medicine provided by the invention, which are both significantly higher than the cure rate (62.5%) and the total effective rate (81.3%) in the control group, with significant difference (P<0.05), the vaginal bleeding period is short, and proportion of the complete curettage of uterine cavity is low.